# lilly (blogs) — RSS Amplifier

Recent posts from the 4 feeds in the RSS Amplifier directory that cover lilly.

Page: <https://rssamplifier.com/topics/lilly/blogs>  
Feed: <https://rssamplifier.com/topics/lilly/blogs.md>

---

## [LIVE @ 11AM CT - The “Exercise Pill”](https://onthepen.substack.com/p/live-11am-ct-the-exercise-pill)

_2026-08-19 · On The Pen GLP-1 News · ON THE PEN_

How could it change obesity treatment?

## [2026 IPO stock tracker: How newly public biotechs are performing](https://www.biospace.com/business/2026-ipo-stock-tracker-how-biotechs-new-to-public-markets-are-performing)

_2026-08-19 · Gabrielle Masson · Biopharma Mergers & Acquisitions_

BioSpace is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.

## [Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars](https://www.biospace.com/drug-delivery/sandoz-inks-322m-henlius-deal-for-rights-to-as-many-as-10-biosimilars)

_2026-08-18 · Nick Paul Taylor · Biopharma Mergers & Acquisitions_

The initial batch of biosimilars includes copies of Amgen, Eli Lilly and GSK drugs that collectively generate billions of dollars in annual revenues.

## [LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug](https://www.biospace.com/business/leo-adds-to-dermatology-portfolio-with-435m-deal-for-late-stage-rare-disease-drug)

_2026-08-18 · Annalee Armstrong · Biopharma Mergers & Acquisitions_

This is the third recent acquisition conducted by Denmark’s LEO Pharma in medical dermatology, a portfolio that marked 12% growth in the first half of the year.

## [Rebounding biotech funds expected to spur CDMO growth within year](https://www.biospace.com/business/rebounding-biotech-funds-expected-to-spur-cdmo-growth-within-year)

_2026-08-18 · Nick Paul Taylor · Biopharma Mergers & Acquisitions_

With demand for pharma services historically lagging changes in biotech funding, analysts expect CDMOs to experience an uptick in activity in late 2026 or early 2027.

## [🔬 Latest pharma industry updates 👇](https://weeklybiopharmaupdates.substack.com/p/latest-pharma-industry-updates-afd)

_2026-08-16 · Nicolas Schmitz · 🔬 Latest Pharma Industry Updates_

🤝 Jazz Pharmaceuticals will acquire Actio Biosciences, Inc. for up to $1.3B, adding a rare epilepsy drug and expanding its neuroscience pipeline.

## [Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M](https://www.biospace.com/deals/zealand-sells-milestone-royalty-rights-to-rare-blood-cancer-asset-for-up-to-100m)

_2026-08-13 · Tristan Manalac · Biopharma Mergers & Acquisitions_

The terms of the agreement with Royalty Pharma suggest the market potential of Zealand Pharma’s polycythemia vera drug candidate may be undervalued, according to Jefferies analysts.

## [Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale](https://www.biospace.com/deals/bankrupt-sangamo-offloads-assets-to-lilly-ptc-in-161m-sale)

_2026-08-13 · Tristan Manalac · Biopharma Mergers & Acquisitions_

PTC Therapeutics emerged as the winning bidder over Astellas for Sangamo Therapeutics’ Fabry disease gene therapy, while Eli Lilly is purchasing the biotech’s prion disease program and several platforms.

## [Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset](https://www.biospace.com/deals/sentynl-bets-up-to-475m-in-licensing-deal-for-mereos-rare-lung-disease-asset)

_2026-08-12 · Tristan Manalac · Biopharma Mergers & Acquisitions_

Mereo BioPharma’s asset, dubbed alvelestat, is set to enter Phase 3 development for AATD-LD in 2027.

## [After billions in deals, Insilico CEO promises: ‘You haven't seen anything yet’](https://www.biospace.com/business/after-billions-in-deals-insilico-ceo-promises-you-havent-seen-anything-yet)

_2026-08-11 · Annalee Armstrong · Biopharma Mergers & Acquisitions_

Insilico Medicine CEO Alex Zhavoronkov’s mad dash across the BIO International Convention in June attracted plenty of eyes. But the executive would prefer industry watchers gawk at the billions of dollars’ worth of deals his company has struck.

## [One platform, from silicon to agent (Sponsored)](https://crawlproof.com/a/gzFOATXZLnC3)

_2026-08-11 · **Sponsored**_

Serverless inference plus Inference Router to optimize cost and latency at scale.

## [Jazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline](https://www.biospace.com/deals/jazz-commits-up-to-1-3b-to-buy-actio-bolster-epilepsy-pipeline)

_2026-08-10 · Gabrielle Masson · Biopharma Mergers & Acquisitions_

Jazz Pharmaceuticals is reaching into its wallet once again, this time buying Actio Biosciences and an experimental therapy for KCNT1+ epilepsy, a form of the disease with no FDA-approved treatments.

## [AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant](https://www.biospace.com/drug-delivery/astrazeneca-partners-with-cspc-to-build-chinese-biologics-manufacturing-plant)

_2026-08-10 · Nick Paul Taylor · Biopharma Mergers & Acquisitions_

News of the joint venture comes months after AstraZeneca vowed to spend $15 billion in China by the end of the decade.

## [I Was Selling Traffic Signals. Then Everything Changed.](https://onthepen.substack.com/p/i-was-selling-traffic-signals-then)

_2026-08-08 · On The Pen GLP-1 News · ON THE PEN_

I’ve Never Told This Part of the On The Pen Story

## [EXCLUSIVE: Wegovy FlexTouch Is Coming to America](https://onthepen.substack.com/p/exclusive-wegovy-flextouch-is-coming)

_2026-08-08 · On The Pen GLP-1 News · ON THE PEN_

Here’s why this is a big deal….

## [LIVE NOW: Lilly Earnings Call Recap! Retatrutide News!](https://onthepen.substack.com/p/live-now-lilly-earnings-call-recap)

_2026-08-05 · On The Pen GLP-1 News · ON THE PEN_

Watch now live, or ondemand later by clicking play below!

## [LIVE NOW: Meet The New Tirzepatide Add On From Lilly (not Eloralintide)](https://onthepen.substack.com/p/live-now-meet-the-new-tirzepatide)

_2026-08-03 · On The Pen GLP-1 News · ON THE PEN_

These are fun videos… The videos where we get to introduce you to new molecules that no one else on the web is talking about.

## [I Think Everyone Is Looking at the Retatrutide Lawsuit the Wrong Way](https://onthepen.substack.com/p/i-think-everyone-is-looking-at-the)

_2026-07-28 · On The Pen GLP-1 News · ON THE PEN_

This matters to anyone watching the GLP-1 space closely

## [The SAFE Drugs Act No Longer a Threat to Compounded GLP-1](https://onthepen.substack.com/p/the-safe-drugs-act-no-longer-a-threat)

_2026-07-26 · On The Pen GLP-1 News · ON THE PEN_

We spoke. Washington listened.

## [BREAKING: Lilly Just Put Retatrutide on the Road to Approval, and Three Letters Changed the Conversation](https://onthepen.substack.com/p/breaking-lilly-just-put-retatrutide)

_2026-07-23 · On The Pen GLP-1 News · ON THE PEN_

The latest in a 2 year long saga...

## [Everyone's installing local LLMs. I bought a rack.](https://orivega.io/everyone-installing-local-llms-i-bought-a-rack/)

_2026-07-20 · squidleon · Hi, I'm \*squid\*_

While everyone chases local LLMs, I did the unfashionable thing and rebuilt my homelab's foundation: a rack, a €25 switch and a €35 router. The plumbing is where the real engineering lives.

## [Ship software peacefully (Sponsored)](https://crawlproof.com/a/SN5qeaFzSCIK)

_2026-07-20 · **Sponsored**_

Deploy apps from your repo with auto-config, instant previews, scaling, and monitoring.

## [This Study Changes the GLP-1 Deficiency Debate](https://onthepen.substack.com/p/this-study-changes-the-glp-1-deficiency)

_2026-07-18 · On The Pen GLP-1 News · ON THE PEN_

This may be one of the most important obesity papers published all year.

## [Boehringer’s Next Obesity Bet Not Just Another Incretin, It’s One of the Brain’s Most Powerful Hunger Pathways](https://onthepen.substack.com/p/boehringers-next-obesity-bet-not)

_2026-07-17 · On The Pen GLP-1 News · ON THE PEN_

Over the past few years, we’ve watched obesity medicines evolve from our favorite GLP-1 therapies we discuss like semaglutide, or dual agonists like tirzepatide, and now to triple agonists like retatrutide.

## [Moongate V2 Dev Log #5: GM Tools, Template Tooling, ModernUO Imports, and Smarter Guards](https://orivega.io/moongate-v2-dev-log-5-gm-tools-template-tooling-modernuo-imports-and-smarter-guards/)

_2026-03-26 · squidleon · Hi, I'm \*squid\*_

This week I added a GM menu, a template validation tool, a dotnet new plugin template, deeper ModernUO import tooling, a cleaner AI runtime, and much better city guards.

## [Moongate V2 Dev Log #4: Combat, Corpses, Scripted NPCs, and a Cleaner Architecture](https://orivega.io/moongate-v2-dev-log-4-combat-corpses-scripted-npcs-and-a-cleaner-architecture/)

_2026-03-19 · squidleon · Hi, I'm \*squid\*_

This week I added combat, corpses, loot chests, scripted NPC dialogue, OpenAI-backed NPC behavior, scheduled events, plugin infrastructure, and a major persistence cleanup to Moongate.

## [Moongate V2 Dev Log #3: Player Portal, Maps, Books, and a .NET Bug I Didn't Own](https://orivega.io/moongate-v2-dev-log-3-player-portal-maps-books-and-a-net-bug-i-didnt-own/)

_2026-03-12 · squidleon · Hi, I'm \*squid\*_

This week I shipped a player portal, better world visibility tools, writable books, and lost two days to a .NET bug that turned out not to be mine.

## [Moongate v2 Dev Log #2 — Three Bugs That Forced an Architecture Upgrade](https://orivega.io/moongate-v2-dev-log-2-three-bugs-that-forced-an-architecture-upgrade/)

_2026-03-06 · squidleon · Hi, I'm \*squid\*_

Three hard production issues in Moongate v2: MemoryPack+AOT crashes, doors shifting when toggled, and single-thread bottlenecks under load.

## [Moongate v2 Dev Log #1: When Your Architecture Lies to You](https://orivega.io/moongate-v2-dev-log-1-when-your-architecture-lies-to-you/)

_2026-02-26 · squidleon · Hi, I'm \*squid\*_

How I fixed the bootstrap, added source generators, and scripted items with Lua in Moongate v2 -- a modern Ultima Online server built with .NET 10.

## [Moongate v2: Rewriting a Ultima Online Server From Scratch (Because I Wanted To)](https://orivega.io/moongate-v2-rewriting-a-ultima-online-server-from-scratch-because-i-wanted-to/)

_2026-02-20 · squidleon · Hi, I'm \*squid\*_

A personal story about nostalgia, a terrible job, and rewriting an Ultima Online server emulator from scratch with .NET 10 and NativeAOT.

## [Small Objectives, AI-Driven Architecture: How Abandoning Dark Lilly Built LillyQuest](https://orivega.io/small-objectives-ai-driven-architecture-how-abandoning-dark-lilly-built-lillyquest/)

_2026-01-23 · squidleon · Hi, I'm \*squid\*_

Sometimes the only way to understand constraint-driven design is to ignore constraints entirely, realize you're drowning, and start over. That's the story of Dark Lilly and LillyQuest. Part 1: The Ambitious Mistake In November 2026, I started Dark Lilly. A DOOM-like engine. 3D. OpenGL 4.1. Sector-based geometry with portal rendering. Room-over-room architecture. Full BSP tree implementation. A…

## [Life as a CTO – Part 1](https://orivega.io/life-as-a-cto-part-1/)

_2026-01-15 · squidleon · Hi, I'm \*squid\*_

First entry of a personal series about the real, human side of being a CTO.

## [Licensed Dispensaries, Pay with Crypto (Sponsored)](https://crawlproof.com/a/AlzjhHTREEcf)

_2026-01-15 · **Sponsored**_

Search verified licensed dispensaries and pay with Bitcoin, Lightning, or stablecoins.

## [Building a DOOM-Like Engine in 2026: Discipline Through Constraints](https://orivega.io/building-a-doom-like-engine-in-2026-discipline-through-constraints/)

_2026-01-14 · squidleon · Hi, I'm \*squid\*_

I'm building (Dark) Lilly Engine, a 3D DOOM-inspired engine in C# with OpenGL. Not to clone DOOM. Not to romanticize the past. But because rebuilding foundational ideas until they're yours is the only way to truly understand them. Sometimes the only way to understand a system is to rebuild it. Not copy it. Not romanticize it. Just rebuild the ideas until they're yours. I'm not building a DOOM…